NDC 68382-696

Ritonavir

Ritonavir

Ritonavir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals Usa Inc. The primary component is Ritonavir.

Product ID68382-696_415d6153-5ad1-0b15-e631-937279e5838c
NDC68382-696
Product TypeHuman Prescription Drug
Proprietary NameRitonavir
Generic NameRitonavir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-03-20
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA022417
Labeler NameZydus Pharmaceuticals USA Inc
Substance NameRITONAVIR
Active Ingredient Strength100 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68382-696-06

30 TABLET, FILM COATED in 1 BOTTLE (68382-696-06)
Marketing Start Date2018-03-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68382-696-06 [68382069606]

Ritonavir TABLET, FILM COATED
Marketing CategoryNDA authorized generic
Application NumberNDA022417
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-03-20
Marketing End Date2020-01-10

Drug Details

Active Ingredients

IngredientStrength
RITONAVIR100 mg/1

OpenFDA Data

SPL SET ID:70f03898-ef3e-d090-71ed-7d3bd0e92098
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 900575
  • UPC Code
  • 0368382696069
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitor [EPC]
    • Protease Inhibitor [EPC]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Cytochrome P450 2C19 Inducers [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Breast Cancer Resistance Protein Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 1A2 Inducers [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]
    • UDP Glucuronosyltransferases Inducers [MoA]

    Medicade Reported Pricing

    68382069606 RITONAVIR 100 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Ritonavir" or generic name "Ritonavir"

    NDCBrand NameGeneric Name
    0054-0407RitonavirRitonavir
    31722-597RitonavirRitonavir
    60687-364RitonavirRitonavir
    60687-420RitonavirRitonavir
    65162-061RitonavirRitonavir
    65862-687RitonavirRitonavir
    68382-696RitonavirRitonavir
    70518-1086RitonavirRitonavir
    70518-1519RitonavirRitonavir
    70518-2007RitonavirRitonavir
    0074-1940NorvirRitonavir
    0074-2340NorvirRitonavir
    0074-3333NorvirRitonavir
    0074-3399NorvirRitonavir
    50090-1162NorvirRitonavir
    53808-1119NorvirRitonavir

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.